HA

Hemalatha Arumugam

Director Director DIN 03510889
DIN 03510889 First appointment Jun 2011 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2011
Shareholding value Locked Premium profile

About Hemalatha Arumugam

Hemalatha Arumugam has 15 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in Technology. Contributes to corporate operations.

DIN 03510889
Primary Designation Director
First Appointment 10 Jun 2011
Oldest Company Age 15 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Hitech Biogenics Private Limited U74900PY2011PTC002599
Director 10 Jun 2011 2011 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hitech Biogenics Private Limited
Premium access

Shareholding and investment profile for Hemalatha Arumugam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemalatha Arumugam

Hemalatha Arumugam has 15 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in Technology. Contributes to corporate operations.

Hemalatha Arumugam is associated with 0 companies as Director.

Hemalatha Arumugam has expertise in Technology.

Hemalatha Arumugam has 15 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available